JavaScript is currently not supported/disabled by this browser. Please enable JavaScript for full functionality.

Call Us 1 - 866 - 986 - 9598
[email protected]

Sign Up

Login
- My Order
- Return Requests
- Track my Order

Home / Proteins & Peptide

Spike S1 (16-685), Avi-His-Tag, Biotin-Labeled (SARS-CoV-2)

SKU : BHP18201259

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Request More Infos

BPS Bioscience

view supplier details

Order Now

Credit card payments now incur a 3% fee.

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Ask Merchant

Request More Infos

Sample Request

Mfr.No.	100731-2
Description	Recombinant SARS-CoV-2 Spike protein, S1 subunit encompassing amino acids 16-685. The construct contains a C-terminal Avi-Tag followed by a His-tag (6xHis). The recombinant protein was affinity purified and enzymatically biotinylated using the Avi-Tag.
Immunogen Region	16-685
Tag	C-terminal Avi-His-Tag
Formulation	8 mM phosphate pH 7.4, 110 mM NaCl, 2.2mM KCl, and 20% glycerol.
Species	SARS-CoV-2
Notes	This protein runs at a higher MW by SDS-PAGE due to glycosylation. This protein is enzymatically biotinylated using Avi-Tag technology. Biotinylation is confirmed to be>=90%. Avoid freeze/thaw cycles.
GenBank	MN908947
Mw(kda)	78 kDa +glycans

Synonyms	SARS-CoV-2 s1, spike receptor binding domain, coronavirus spike S1, 100731-1, 100731-2
Uniprot	P0DTC2 SPIKE_WCPV

Shipping Temperature	-80°C (dry ice)
Purity	0.85
Storage	At least 6 months at -80°C.

Product Manual	Datasheet

Have you used this product?

Rate it now..!!

Login to Review

SKU	Supplier No.	Size	Your price	Quantity
BHP18201259	100731-2	50 ug	$500.50		Add to Cart

ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.

© 2024 Biohippo. All rights reserved.